Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
Biological Psychiatry|July 1, 1993
A cross-national EEG study of children with emotional and behavioral problems: a WHO collaborative study in the Western Pacific RegionM Matsuura, Y Okubo, M Toru, et al.
Journal of Psychiatric Research|October 28, 1998
Exploratory eye movement dysfunctions in patients with schizophrenia: possibility as a discriminator for schizophreniaE Matsushima, T Kojima, K Ohta, et al.
Acta Psychiatrica Scandinavica|August 1, 1988
Neurotransmitters, receptors and neuropeptides in post-mortem brains of chronic schizophrenic patientsM Toru, S Watanabe, H Shibuya, et al.
American Journal of Medical Genetics|April 9, 1996
Further association study on dopamine D2 receptor variant S311C in schizophrenia and affective disordersT Arinami, M Itokawa, J Aoki, et al.
Alcoholism, Clinical and Experimental Research|August 12, 1999
Association between drinking-related antisocial behavior and a polymorphism in the serotonin transporter gene in a Japanese populationH Ishiguro, T Saito, S Akazawa, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine|March 1, 1996
[A phase 3 clinical trial of 123I-iomazenil, a new central-type benzodiazepine receptor imaging agent (Part 1)--report on clinical usefulness in diagnosis of various brain diseases]K Torizuka, K Uemura, M Toru, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine|March 1, 1996
[A phase 3 clinical trial of 123I-iomazenil, a new central-type benzodiazepine receptor imaging agent (Part 3)--Report on clinical usefulness in epilepsy]K Torizuka, K Uemura, M Toru, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine|March 1, 1996
[A phase 3 clinical trial of 123I-iomazenil, a new central-type benzodiazepine receptor imaging agent (Part 4)--Report on clinical usefulness in diagnosis of cerebrovascular diseases]K Torizuka, K Uemura, M Toru, et al.
Psychiatry and Clinical Neurosciences|June 17, 1998
Cerebral blood volume in the sleep measured by near-infrared spectroscopyS Shiotsuka, Y Atsumi, S Ogata, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine|March 1, 1996
[A phase 3 clinical trial of 123I-iomazenil, a new central-type benzodiazepine receptor imaging agent (Part 2)--Report on clinical usefulness in diagnosis of degenerative neurological diseases and mental disorders]K Torizuka, K Uemura, M Toru, et al.
Pageof 10